Blueprint
Musclepharm Corporation
4400
Vanowen Street
Burbank, CA
91505
(303)
396-6100
January
10, 2018
BY EDGAR
Securities and Exchange
CommissionOffice of Global Security Risk
Division
of Corporation Finance
100 F
Street, N.E.
Washington,
D.C. 20549
Attn:
Cecilia Blye
|
|
Re:
Comment
Letter Dated December 22, 2017
Form
10-K for Fiscal Year Ended December 31, 2016
Dear
Ms. Blye:
Musclepharm
Corporation (the “Company”) hereby submits
a request for an extension to respond to the comment letter
referenced above until January 22, 2018. Due to reduced resources
available at the Company during the recent holiday break, the
Company will require additional time to prepare its
response.
If you
have any questions relating to the foregoing, please contact the
undersigned at (818) 658-3806.
|
Sincerely,
Musclepharm
Corporation
By: /s/ Kevin
Harris
Name:
Kevin Harris
Title: Interim
Chief Financial Officer
|